2005
DOI: 10.1073/pnas.0502440102
|View full text |Cite
|
Sign up to set email alerts
|

Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5–E3 ligase through a HCCH motif to suppress APOBEC3G

Abstract: Cullin-Ring E3 ubiquitin ligases target substrates for ubiquitindependent, proteasome-mediated degradation and regulate critical cellular processes. These cullins assemble with cellular substrate receptor proteins through specific adaptor molecules. F-box-and BC-box-containing receptors use Skp1, ElonginB, and ElonginC as adaptors to recruit Cul1͞Cul7 and Cul2͞Cul5, respectively. At present, the determinants of Cul2 vs. Cul5 specificity for the BC-box-containing receptors are poorly defined. Here, we demonstra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
196
3
1

Year Published

2006
2006
2017
2017

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 164 publications
(206 citation statements)
references
References 37 publications
6
196
3
1
Order By: Relevance
“…Lentiviruses such as HIV-1 and SIV encode the Vif protein, which assembles with cellular proteins Cul5, ElonginB and ElonginC to form an E3 ubiquitin ligase (Yu et al, 2003;Mehle et al, 2004;Kobayashi et al, 2005;Liu et al, 2005;Luo et al, 2005) that induces polyubiquitination and degradation of multiple APOBEC3 molecules (Conticello et al, 2003;Marin et al, 2003;Sheehy et al, 2003;Stopak et al, 2003;Yu et al, 2003;Liu et al, 2004;Mehle et al, 2004;Liu et al, 2005). Exogenous expression of APOBEC3G (A3G) and APOBEC3F (A3F) has also been found to reduce HBV core-associated DNA in transfected liver cell lines (Rosler et al, 2004;Turelli et al, 2004a,b;Noguchi et al, 2005;Suspene et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…Lentiviruses such as HIV-1 and SIV encode the Vif protein, which assembles with cellular proteins Cul5, ElonginB and ElonginC to form an E3 ubiquitin ligase (Yu et al, 2003;Mehle et al, 2004;Kobayashi et al, 2005;Liu et al, 2005;Luo et al, 2005) that induces polyubiquitination and degradation of multiple APOBEC3 molecules (Conticello et al, 2003;Marin et al, 2003;Sheehy et al, 2003;Stopak et al, 2003;Yu et al, 2003;Liu et al, 2004;Mehle et al, 2004;Liu et al, 2005). Exogenous expression of APOBEC3G (A3G) and APOBEC3F (A3F) has also been found to reduce HBV core-associated DNA in transfected liver cell lines (Rosler et al, 2004;Turelli et al, 2004a,b;Noguchi et al, 2005;Suspene et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…The Vif N-terminal region contains several conserved Trp residues that are required for Apo3G recognition (22). HIV-1 Vif C114S and C133S mutants do not bind to Cul5 (9,10), and mutation of the conserved His and Cys residues of the HCCH motif in SIV AGM Vif inhibits Cul5 binding (12). Therefore, it appears that the Vif N-terminal region mediates Apo3G recognition (22), whereas the HCCH motif allows specific binding to Cul5 (12).…”
mentioning
confidence: 99%
“…Vif promotes the ubiquitination and proteasomal degradation of Apo3G (5)(6)(7)(8). Interaction of Vif with a Cullin 5 (Cul5)-based E3 ligase is required for Apo3G degradation (9)(10)(11), and a recent study suggests that the conserved H-X 5 -C-X 17-18 -C-X 3-5 -H (HCCH) motif plays a vital role in the Vif-Cul5 interaction (12).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The SLQ( Y/F)LA motif (amino acids 144-150) of Vif interacts directly with elongin C (Marin et al 2003;Yu et al 2003Yu et al , 2004cMehle et al 2004a,b). A cryptic zinc-coordination motif, His-Xaa 5 -Cys-Xaa 17-18 -Cys-Xaa 3-5 -His (HCCH, amino acids 108-139), connects Vif to cullin 5 (Luo et al 2005;Mehle et al 2006;Xiao et al 2006). Through these interactions, Vif recruits a ubiquitin ligase (E3) complex comprising elongin C, elongin B, cullin 5, Nedd8 and Rbx1 ( Yu et al 2003( Yu et al , 2004c) that mediates the polyubiquitylation and triggers degradation of A3G (Conticello et al 2003;Marin et al 2003;Sheehy et al 2003;Stopak et al 2003).…”
Section: Further Insights Into Vif Actionmentioning
confidence: 99%